Targeting aberrant kinase activity in cancer relies on unmasking cellular inputs such as growth factors, nutrients, and metabolites that contribute to cancer initiation and progression 1 . While the transition metal copper (Cu) is an essential nutrient that is traditionally viewed as a static cofactor within enzyme active sites 2 , a newfound role for Cu as a modulator of kinase signaling is emerging 3, 4 . We discovered that Cu is required for the activity of the autophagic kinases ULK1/2 through a direct Cu-ULK1/2 interaction. Genetic loss of the Cu transporter Ctr1 or mutations in ULK1 that disrupt Cu-binding reduced ULK1/2-dependent signaling and autophagosome complex formation. Elevated intracellular Cu levels are associated with starvation induced autophagy and sufficient to enhance ULK1 kinase activity and in turn autophagic flux. Targeting autophagy machinery is a promising therapeutic strategy in cancers 5 , but is limited by the absence of potent inhibitors and the emergence of resistance. The growth and survival of lung tumors driven by KRAS G12D is diminished in the absence of Ctr1, depends on ULK1 Cu-binding, and is associated with reduced autophagy levels and signaling. These findings suggest a new molecular basis for exploiting Cu-chelation therapy to forestall autophagy signaling to limit proliferation and survival in cancer.
pigmentation 7 . The importance of intact Cu homeostatic mechanisms for cell growth control is underscored by the stunted growth and failure to thrive associated with Cu deficiency in Menkes disease patients 8 and the increased prevalence of cancer in patients and animal models with hereditary Cu overload in Wilson disease [9] [10] [11] . However, the dysregulated growth phenotypes associated with alterations in Cu availability cannot be fully explained by the limited number of Cu-dependent enzymes that traditionally harness the redox potential of Cu as a structural or catalytic cofactor.
Several recent studies have illuminated novel functions for Cu as a non-structural intracellular mediator of signaling by directly connecting Cu to signaling pathway components that modulate cell proliferation or lipid metabolism 3, 4, 12 . We previously showed that in response to growth factors, Cu contributes to the amplitude of canonical MAPK signaling through an interaction between Cu and the kinases MEK1 and MEK2 3 . Examination of this new signaling mechanism in the context of cancer revealed that BRAF V600E -driven tumors depend on MEK1/2 association with Cu, and moreover, are sensitive to Cu-chelating drugs 4, 13, 14 . In Wilson disease, Cu influences 3',5'-cyclic AMP (cAMP)-mediated lipolysis downstream of β-adrenergic receptor signaling by directly inhibiting the phosphodiesterase PDE3B 12 , serving as one molecular mechanism to explain the connection between aberrant Cu accumulation and altered lipid metabolism 10 . These findings bolster a new paradigm linking Cu levels to signaling pathway components that are essential for normal physiology, but that become dysregulated in multiple disease states including cancer. Thus, uncovering additional kinases that are regulated by Cu levels is needed to further define Cu-dependent cellular processes that may contribute to the efficacy of Cu chelators for cancer therapy 15 .
To explore other Cu-dependent kinases, we first performed an alignment of the Cu-binding sequence in MEK1 4 against kinase domains and identified the autophagy regulatory kinases ULK1 and ULK2 as sharing significant sequence similarity at the amino acids (H188, M230, and H239) required for Cu-binding in MEK1 (Fig. 1a ). Both ULK1 and ULK2 bind to a Cu-charged resin, but not a metal free resin control, Fe-, or Zn-charged resin (Fig. 1b,c) . To investigate the impact of Cu-binding to ULK1 and ULK2 function, we first tested whether Cu is directly required for ULK1 and ULK2 kinase activity. ULK1 and ULK2 in vitro kinase activity was enhanced in response to increasing concentrations of CuCl2 (Fig. 1d,e and Supplementary Fig. 1e ,f) and inhibited when treated with increasing concentrations of the Cu chelator tetrathiomolybdate (TTM) ( Fig. 1f,g and Supplementary Fig. 1g,h) . The reduced ULK1 and ULK2 kinase activity in presence of TTM was similar to inhibition achieved with the ULK1/2 inhibitor MRT68921 16 (Fig. 1f,g and Supplementary Fig. 1g,h) . ULK1/2 are well-established downstream targets of the protein kinase mammalian target of rapamycin (mTOR) [17] [18] [19] [20] . When associated with rapamycin-sensitive mTOR complex 1 (mTORC1) 21 , mTOR controls cellular energetics by driving anabolic processes, such as lipid, nucleotide, and protein synthesis 22 , and suppressing catabolic processes [17] [18] [19] [20] , like autophagy. mTOR kinase activity is blocked in response to amino acid deprivation [23] [24] [25] , low cellular ATP levels 26, 27 , or rapamycin treatment 28, 29 . This in turn relieves the inhibitory phosphorylation of ULK1 and ULK2 and initiates the formation of an autophagosome [17] [18] [19] [20] , which degrades and recycles proteins, lipids, and organelles to restore nutrient balance in the form of building blocks for metabolic pathways. To investigate the relationship between Cu and mTORC1-ULK1/2 signaling in mammalian cells, Cu-replete and Cu-deficient cells were generated by expressing the high affinity Cu transporter CTR1 (WT) or an empty vector (VO) in immortalized Ctr1 -/mouse embryonic fibroblasts (MEFs). Intracellular Cu levels in CTR1 WT expressing Ctr1-null MEFs are comparable to Ctr1 +/+ MEFs as confirmed by reduced CCS protein stability 30 , which is degraded in a Cu-dependent fashion, increased Cu levels via inductively coupled plasma mass spectrometry (ICP-MS), and elevated fluorescence from the CF4 probe 31 , which detects labile Cu ( Fig. 1d and Supplementary Fig. 1a-d ). Ctr1 loss reduced ULK1-mediated phosphorylation of ATG13 under basal conditions and the elevated phosphorylation of ATG13 that occurs upon amino acid deprivation [17] [18] [19] [20] was only observed in the Cu-replete conditions ( Fig. 1d and Supplementary Fig.   1i ). In contrast, PI3K/AKT signaling-mediated phosphorylation 32 of mTOR S2448 and mTOR phosphorylation [33] [34] [35] of ULK1 S757 , p70S6K T389 , and mTOR S2481 remained unchanged upon reduced Cu levels (Fig. 1d ). These data suggest that Cu is required for ULK1 activity but not its upstream regulation by mTORC1 or mTOR itself. In agreement, ULK1 kinase activity is elevated upon amino acid withdrawal in Cu-replete cells but is blunted in the Cu-deficient cells ( Fig. 1i and Supplementary Fig. 1j ). Additionally, MEFs lacking the Cu exporter Atp7a, which have elevated intracellular Cu levels, also had increased ULK1 kinase activity ( Fig. 1j and Supplementary Fig.  1k ). These findings that reduced Cu levels decrease ULK1/2-dependent signaling downstream of mTORC1 inhibition ( Fig. 1h -j) suggest that autophagy may be a newly identified Cu-dependent process.
The ULK1-ATG13 complex senses low-energy and nutrient depleted cellular states and initiates autophagosome formation [17] [18] [19] [20] . To determine whether changes in levels of Cu affect ULK1/2-dependent autophagy, Cu-replete or Cu-deficient MEFs were exposed to amino acid deprivation [23] [24] [25] or rapamycin 28, 29 , which inhibit mTOR. Specifically, autophagic flux was measured by three techniques, including i) Western blot analysis of the processing of LC3 from its full-length form (LC3-I) to its cleaved and phosphatidylethanolamine-conjugated form (LC3-II) 36 , ii) flow cytometry measurement of the ratio of autolysosomes (mCherry-LC3B) to autophagosomes (EGFP-LC3B) 37 , and iii) immunofluorescence detection of the abundance of autophagosomes (mCherry-EGFP-LC3 positive puncta) and autolysosomes (mCherry-LC3 positive puncta) 38 . These studies revealed that loss of Ctr1 significantly reduced LC3-I processing ( Fig. 1k and Supplementary Fig. 1l ) and prevented autophagosome to autolysosome conversion upon autophagy induction ( Fig. 1l-n) . Further, under basal conditions the number of mCherry-EGFP-LC3 positive puncta was significantly reduced, indicating a potential block in autophagosome formation and in turn recruitment of LC3B ( Fig. 1m,n) . In contrast, CRISPR/Cas9-mediated knockdown of endogenous Atp7a ( Supplementary Fig. 1m ) caused elevated Cu levels that were sufficient to enhance LC3-II levels ( Fig. 1o ) and autophagic flux ( Fig.   1p -r). Collectively, these data suggest that the levels of Cu could serve as a rheostat for ULK1/2dependent autophagy by regulating ULK1/2 kinase activity in an mTOR-dependent fashion.
Since altering Cu levels has been shown to affect MAPK signaling 3, 4 , we interrogated the contribution of the MAPK pathway to Cu-mediated regulation of autophagy via genetic and pharmacologic approaches. First, we directly tested whether disrupting MEK1 Cu-binding was sufficient to reduce autophagy in the presence (Ctr1 flox/flox ) or absence (Ctr1 -/-) of Cu transport.
While expression of Cu-binding mutant (CBM) of MEK1 4 reduced phosphorylation of ERK1/2 ( Supplementary Fig. 1o ), LC3-II levels were unchanged and Cu-dependent autophagic flux was still observed in Ctr1 -/-MEFs ( Supplementary Fig. 1p,q) . Second, treatment with the MEK1/2 inhibitor, trametinib, which abolished phosphorylation of ERK1/2, did not phenocopy the reduced autophagic flux in the absence of Ctr1 ( Supplementary Fig. 1r ,s). Consistent with these findings, expression of a gain-of-function (GOF) ERK2 mutant 4 , which bypasses the ability of Cu to influence MEK1/2 activity in Ctr1 -/-MEFs ( Supplementary Fig. 1t ), did not increase LC3-II levels in cells devoid of significant Cu transport ( Supplementary Fig. 1u ,v). Finally, while increasing Cu levels via Atp7a knockdown is sufficient to increase phosphorylation of ERK1/2 ( Fig. 1o ), loss of Atp7a in MEFs lacking the key autophagy regulator Atg5 ( Supplementary Fig. 1m ), which is part of the ubiquitin-like conjugation system that lipidates LC3 36 , failed to re-establish autophagy ( Supplementary Fig. 1w ). Collectively, these data indicate that Cu-dependent autophagy is mechanistically independent of Cu-regulated MEK1/2 activity and upstream of ATG5, which is required for autophagosome nucleation.
Since our findings suggest that Cu is required for ULK1/2-dependent signaling and autophagic flux in response to mTOR inhibition, we next hypothesized that Cu levels may fluctuate in an acute manner after autophagy induction. Interestingly, a statistically significant elevation in labile intracellular Cu levels, as measured by increased fluorescence of the Cu probe CF4 31 and not its control (Ctrl-CF4) 31 , was detected in a time-dependent fashion post amino acid withdrawal ( Fig. 2a,b , Supplementary Fig. 2a ,b, and Supplementary Video 1-4). Thus, the requirement for Cu for efficient autophagic flux is driven by Cu fluctuations that support ULK1/2 kinase activity.
While ULK1/2 activation is typically a prerequisite for LC3 processing by the ubiquitin-like conjugation system on the forming autophagosome 17 , several upstream ULK1/2-dependent molecular events are essential to initiate autophagosome formation 39, 40 ( Supplementary Fig. 2c ).
Specifically, active ULK1 translocates to the ER with its constitutive binding partners ATG13 and FIP200 to drive phagophore formation by phosphorylating core components of the class III PI3K VPS34 complex, which includes BECLIN-1, PIK3R4 (p150), and VPS34 itself [17] [18] [19] [20] [41] [42] [43] . The ULK1-mediated phosphorylation of BECLIN-1 or ATG14 within VPS34 complex 1 stimulates VPS34 activity, which converts phosphatidylinositol to PI3P 43, 44 . The generation of PI3P serves as a docking site for FYVE domain containing proteins, like DFCP1 and WIPI1, that recruit the ubiquitin like conjugation complex ATG5-ATG12-ATG16 to lipidate LC3B 39, 45 . To dissect the contribution of Cu to the molecular events directly downstream of ULK1-dependent autophagosome formation, we visualized ULK1 complex translocation to puncta, (EGFP-ATG13 or EGFP-FIP200), VPS34 complex PI3P generation on puncta (EGFP-DFCP1), and PI3P effector translocation to puncta (EGFP-WIPI1) in response to amino acid deprivation in the presence (Ctr1 flox/flox ) or absence (Ctr1 -/-) of Cu transport. Cu deficiency significantly decreased both ATG13, FIP200, WIPI1, and DFCP1 puncta formation in response to amino acid deprivation, indicating that Cu transport contributes to the early steps of phagophore nucleation ( Fig. 2c-j ).
Defective recruitment of these initiating complexes and PI3P production, limited the number of EGFP-LC3 positive autophagosomes measured by flow cytometry 46 (Fig. 2k and Supplementary   Fig. 2d ), an effect that was rescued by loss of the Cu exporter Atp7A (Fig. 2l) . A selective requirement for Cu in the regulation of autophagosome formation was observed, as the Cu chelator TTM reduced EGFP-LC3 positive autophagosome number, while the iron (Fe) chelator desferoxamine (DFO) had no effect ( Supplementary Fig. 2e ,f). These findings suggest that ULK1/2-driven autophagy initiation requires Cu transport.
Increased levels of basal autophagy in some cancers represents a vulnerability to autophagy inhibition 5 . BRAF V600E -driven lung adenocarcinomas require autophagy to preserve mitochondrial function and supply metabolic substrates to support tumor growth 47 . We previously demonstrated that genetic ablation of Ctr1 reduced BRAF V600E -driven lung tumor development, leading to a survival advantage 4 . While the reliance of BRAF V600E -driven tumors on both autophagy 47 and Cu transport 4 could be exploited therapeutically, activating mutations in KRAS are the most common driver event in this disease 48 . Importantly, oncogenic Kras G12D -driven lung adenocarcinomas also depend on efficient autophagy for tumor maintenance 49 . Deletion of the critical autophagy component Atg7 converts Kras G12D -driven adenomas and adenocarcinomas to oncocytomas, a benign tumor type characterized by an accumulation of dysfunctional mitochondria 49 Fig. 3a,b ). Tumor volume at 16 weeks was significantly decreased in mice with CRISPR-mediated deletion of Ctr1 (Fig. 3b,d ,j). Ctr1 loss was confirmed by increased CCS levels in the tumor tissue ( Fig. 3c ,e,k). Molecularly, the established Ctr1 deficient KPLuc tumors had decreased LC3-positive staining, increased p62-positive staining, and reduced autophagosome number, indicative of diminished autophagy ( Fig. 3f ,g,h,l,m,n). Thus, the loss of Ctr1 mitigates KRAS G12D -mediated autophagy that is necessary for lung tumor growth.
Interestingly, several recent studies reported that genetic disruption of oncogenic KRAS or MAPK pathway inhibition elicits protective autophagy via an ULK1-dependent signaling mechanism and indicate that dual targeting of the canonical MAPK pathway and autophagy may be necessary for anti-tumorigenic activity in KRAS-driven tumors [50] [51] [52] . In agreement with our findings that Cu is necessary for MEK1/2 4 ( Supplementary Fig. 3e ). Targeted disruption of Ctr1 reduced LC3-II levels in two KP lung adenocarcinoma cell lines as compared to cells transduced with a non-targeting control sgRNA ( Fig. 3p and Supplementary Fig. 3f ). The dependency of KRAS-driven cancer cell lines on autophagy for growth and survival has been previously evaluated in vitro with clonogenic survival assays ( Fig. 3q ), in which cancer cells are plated in normal media, subsequently starved of amino acids for one day to induce autophagy, and then recovered in normal media for three days, and the ability of the cancer cells to survive is assessed 53 . In agreement with Guo et al. 53 , CRISPR/Cas9 knockout of Atg5 in KP lung adenocarcinoma cells significantly reduced the clonogenic survival of cells post starvation, an effect that was phenocopied by Ctr1 deletion (Fig. 3r,s) . Importantly, expression of ERK2 GOF was not sufficient to rescue the decrease in clonogenic survival in the absence Atg5 or Ctr1 ( Supplementary Fig. 3g ,h), which suggests that the survival of these lung cancer cells depends on autophagy in a MAPK-independent fashion. Nevertheless, our collective results demonstrate that the dependence of KRAS G12D -driven tumors on MAPK signaling and autophagy events can be inhibited by altering Cu levels, which could be achieved with Cu chelators alone.
To mechanistically interrogate the contribution of Cu-binding to ULK1 signal transduction and autophagy initiation, we next mutated H136, M188, and H197 to alanine, which share conserved primary sequence with the Cu-binding mutant (CBM) of MEK1 4 (Fig. 1a ). Compared to wild-type ULK1, the ULK1 CBM had reduced in vitro ability to bind a Cu-charged resin and phosphorylate ATG13 ( Fig. 4a,b ). While the lack of ULK CBM in vitro kinase activity could suggest a Cu-binding independent finding, we previously demonstrated that introduction of mutations at these conserved residues in MEK5, which is highly similar to MEK1/2 and does not bind Cu, did not alter MEK5 kinase activity 4 . Along these lines, the ULK1 CBM immunoprecipitated from Ulk1/2 -/-MEFs deprived of amino acids failed to phosphorylate ATG13 as compared to the exogenous ULK1 WT (Fig. 4c ). While both ULK1 WT and ULK1 CBM were efficiently phosphorylated by AMPK at serine 555 and mTORC1 at serine 757 when stably expressed in Ulk1/2 -/-MEFs ( Supplementary Fig. 4a ), the ULK1 CBM exhibited a mobility shift that corresponded to reduced ULK1 autophosphorylation due to defective kinase activity ( Supplementary Fig. 4b ). Further, despite decreased kinase activity the ULK1 CBM retained strong interactions with canonical binding partners ATG13, ATG101, and FIP200, suggesting that the three-dimensional structure of ULK1 is not destabilized upon introduction of mutations into ULK1 CBM ( Supplementary Fig. 4c ). To evaluate the consequence of disrupting ULK1 Cu-binding on autophagic flux, signaling, and autophagosome formation, Ulk1
and Ulk2 knockout MEFs were generated via CRISPR/Cas9 and validated to have reduced autophagic flux in response to amino acid deprivation, but as previously reported still retain visible levels of LC3-II 54 ( Supplementary Fig. 4d-f ). Only expression of ULK1 WT partially rescued LC3-II levels, phosphorylation of ATG13, and autophagosome formation in the context of Ulk1/2 deficiency, indicating that Cu binding is required to restore autophagic flux downstream of ULK1 ( Fig. 4d-j and Supplementary Fig. 4g ,h). Finally, consistent with Cu-dependent autophagy acting solely through ULK1/2, we found that loss of Ctr1 in MEFs deficient in Ulk1/2 does not further alter autophagic flux ( Fig. 4k and Supplementary Fig. 4i ), as measured by LC3-II levels. This further bolsters the conclusion that Cu levels mechanistically contribute to autophagy via ULK1/2 and not another Cu-dependent parallel pathway.
To translate our finding that Cu-binding to ULK1 is required for autophagy to KRAS-driven tumorigenesis, we next tested and found that blocking ULK1 Cu-binding was associated with reduced tumor growth kinetics and endpoint tumor weight of KRAS G12D -transformed Ulk1 -/immortalized MEFs stably expressing the ULK1 CBM compared to ULK1 WT ( Supplementary Fig.   5a -c). To investigate whether these results could be extrapolated to the setting of endogenous oncogenic KRAS tumorigenesis, Ulk1 and Ulk2 were knocked out by CRISPR/Cas9 in mouse KRAS mutant lung adenocarcinoma cell lines ( Supplementary Fig. 5d ). As expected, loss of endogenous Ulk1/2 decreased the levels of LC3-II and phosphorylation of ATG13 (Fig. 5a,b and Supplementary Fig. 5e ,f). Targeted disruption of Ulk1/2 reduced in vivo tumor growth to a similar extent to loss of Atg5 ( Fig. 5c-e ). In agreement with Cu being required for ULK1 kinase activity, only ULK1 WT , but not ULK1 CBM could partially restore autophagic flux, signaling, and efficient subcutaneous tumor growth ( Fig. 5a-e ). Given that Cu mechanistically contributes to autophagy via ULK1/2, the clonogenic survival of KP adenocarcinoma cells was dependent on ULK1/2 but was not further exacerbated by deletion of Ctr1 (Fig. 5f,g and Supplementary Fig. 5g ). Together, these data support a new mechanism to regulate ULK1 activity via Cu binding to promote nutrient deprived or oncogene-driven autophagy that is required for tumorigenesis.
Despite evidence that Cu homeostasis is essential for life 7 , relatively little is known about cellular pathways that respond directly to Cu levels. We show here that Cu directly modulates the activity of the autophagic kinases ULK1 and ULK2 to function as an endogenous rheostat to control autophagy during nutrient deprivation. These findings highlight a molecular basis for a novel Cu-dependent cellular process to support energy homeostasis. One enticing hypothesis is that sensing Cu abundance through dynamic signaling networks may help cells adapt to environmental changes that would require differential cellular metabolism. By extension, limiting Cu availability or decreasing the binding of Cu to ULK1 may be an attractive therapeutic opportunity to reduce the growth of oncogene-driven lung adenocarcinomas that in part rely on autophagy for tumor maintenance and cell survival. Further, while targeting protein kinase catalytic activity is a proven approach in the landscape of cancer therapeutics, orthogonal approaches that exploit the Cu-dependency of kinases that are critical for maintaining cellular processes essential for tumor growth, such as autophagy, represents an untapped therapeutic opportunity. Correspondence and requests for materials should be addressed to D.C.B.
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(bradyd@pennmedicine.upenn.edu). Addgene plasmid #53203) 4 , pMXs-IP-EGFP-ATG13 (Addgene plasmid #38191) 19 , pMXs-IP-EGFP-FIP200 (Addgene plasmid #38192) 62 , pMXspuro-EGFP-DFCP1 (Addgene plasmid #38269) 39 , pMXs-IP-EGFP-WIPI1 (Addgene plasmid #38272) 39 , and pLentiCRISPRv2Cre
Figure Legends
(Addgene plasmid #82415) 63 were previously described. The TRC cloning vector pLKO.1 expressing the mouse Mek1 shRNA target sequence 5'-CCTGGAGATCAAACCCGCAAT-3'
was obtained from the High-Throughput Screening Core at the University of Pennsylvania.
pLentiCRISPRV2puro-Atg5-sgRNA expressing the mouse Atg5 target sequence 5'-TTCCATGAGTTTCCGATTGA was obtained from GenScript. pBABEbleo-mCherry-EGFP-LC3B was created by PCR subcloning mCherry-GFP-LC3B from pBABEpuro-mCherry-EGFP-LC3B plasmid (Addgene plasmid #22418) 59 with primers designed to N-terminus of mCherry and C-terminus of LC3B. pLenti-CRISPRV2blasti-Rosa26-sgRNA was created to express the mouse Rosa26 target sequence 5'-CCCGATCCCCTACCTAGCCG. pLentiCRISPRV2blasti-Atp7a-sgRNA #1 was created to express the mouse Atp7a target sequence 5'-TCTATAGGGCAAAACCTCCG. pLentiCRISPRV2blasti-Atp7a-sgRNA #2 was created to express the mouse Atpa7a target sequence 5'-AGGGATCTTCTACTGCTCTG.
pLentiCRISPRV2puro-Ctr1-sgRNA #1 was created to express mouse Ctr1 target sequence 5'-TTGGTAATCAATACACCTGG. pLentiCRISPRV2blasti-Ctr1-sgRNA #2 was created to express mouse Ctr1 target sequence 5'-GGACTCAAGATAGCCCGAGA. pLentiCRISPRV2Cre-Ctr1-sgRNA #2 was created to express mouse Ctr1 target sequence 5'-GGACTCAAGATAGCCCGAGA. pETDUET-6XHIS-TEV-HA-ULK1 WT , pBABEbleo-HA-ULK1 WT , and pWZLblasti-HA-ULK1 WT were created by PCR subcloning ULK1 WT from pRK5-HA-ULK1 WT (Addgene plasmid #31963) 20 In vitro kinase assays. ULK1 and ULK2 in vitro kinase assays were performed as previously described for MEK1 kinase assays 3 on a mixed C567B16/129Sv4 background and were previously described 64, 65 . Mice were given lentivirus expressing Cas9, Cre recombinase, and b-Gal sgRNA or Ctr1 sgRNA from pLentiCRISPRv2Cre generated as previously described at 6x10 4 pfu per mouse by intratracheal intubation at 6-10 weeks of age as previously described 63 Clonogenic survival assays. Cells were seeded at 80,000 cells/well in 12-well plates and 24 hours later washed with PBS and media was changed to EBSS. After 24 hours, EBSS was removed and replaced with media. Cells were fixed and stained with 500uL crystal violet solution (0.5%) for 15 minutes after 24, 48, and 72 hours. Cells were washed with deionized water and plates allowed to dry before images were taken with the BioRad Chemidoc Imaging System. Cells were destained by adding 1 mL of 10% acetic acid/well and plates were rocked for 20 minutes at room temperature. Samples from each well were transferred to a 96-well plate, and 590nM absorbance was read on a Synergy HT plate reader (BioTek Instruments). Statistical analysis of 590nM absorbance was performed using a two-way ANOVA followed by Tukey's multi-comparison test in Prism 7 (Graphpad). 
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